Women in the region are waiting up to 18 months for their mammograms, despite the Quebec target of a six-week wait time.

CLEVELAND, Ohio — A genomic test used to assess prostate cancer risk may also help doctors determine which patients are ...

Lynch syndrome is a symptomless genetic condition that increases the risk of developing multiple cancers. 95% of Americans ...

New findings suggest that a blood test can detect circulating tumor DNA (ctDNA), potentially identifying signs of lung cancer ...

Healthcare teams consider age, family history, breast density and other risk factors together to determine which screening ...

Healthcare teams consider age, family history, breast density and other risk factors together to determine which screening ...

Despite being one of the deadliest cancers, pancreatic screening carries more risks than benefits for average-risk patients, ...

A new blood test could detect lung cancer recurrence months before it appears on scans, potentially enabling earlier ...

Abbott’s next-gen Oncodetect molecular residual disease (MRD) test detects traces of circulating tumor DNA in a patient’s ...

A molecular test could help doctors decide which men with high-risk prostate cancer need additional hormone treatment, ...

Even if Theranos had a functioning testing machine, the economic model on which is was based would result in failure,” writes ...

For more than 12 years, Abbott's cancer diagnostics business has helped expand access to colorectal cancer screening through ...